Fertility drugs don't raise risk of uterine cancer recurrence

12/26/2012 | PhysiciansBriefing.com

Women who took fertility drugs after fertility-sparing therapy for uterine cancer were not more likely to experience recurrence than those who didn't receive fertility drugs, according to a review in the journal Obstetrics & Gynecology. Researchers looked at data on 141 patients and found a similar rate of five-year disease-free survival among women who did and didn't take fertility treatments.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR